These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1744450)

  • 1. Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis.
    Harada H; Miyake H; Ochi K; Tanaka J; Kimura I
    Int J Pancreatol; 1991; 9():75-9. PubMed ID: 1744450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis.
    Yang CY; Chang-Chien CS; Liaw YF
    Pancreas; 1987; 2(6):698-700. PubMed ID: 3125546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.
    Büchler M; Malfertheiner P; Uhl W; Schölmerich J; Stöckmann F; Adler G; Gaus W; Rolle K; Beger HG
    Gastroenterology; 1993 Apr; 104(4):1165-70. PubMed ID: 8462805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J; Melzer P; Schmidt FW; Horbach L
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabexate mesilate in the treatment of acute pancreatitis.
    Pederzoli P; Bassi C; Falconi M; De Santis L; Uomo G; Rabitti PG; Talamini G; Cavallini G
    Ann Ital Chir; 1995; 66(2):191-5. PubMed ID: 7545361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
    Freise J
    Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
    Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
    Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
    Hirano T; Manabe T; Tobe T
    J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.
    Pederzoli P; Cavallini G; Falconi M; Bassi C
    Int J Pancreatol; 1993 Oct; 14(2):117-24. PubMed ID: 7506742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis.
    Andriulli A; Leandro G; Clemente R; Festa V; Caruso N; Annese V; Lezzi G; Lichino E; Bruno F; Perri F
    Aliment Pharmacol Ther; 1998 Mar; 12(3):237-45. PubMed ID: 9570258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis.
    Valderrama R; Pérez-Mateo M; Navarro S; Vázquez N; Sanjosé L; Adrián MJ; Estruch J
    Digestion; 1992; 51(2):65-70. PubMed ID: 1499875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
    Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
    Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
    Dabrowski A; Gabryelewicz A
    J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
    Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
    Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect and cost of treatment for acute pancreatitis with or without gabexate mesylate: a propensity score analysis using a nationwide administrative database.
    Yasunaga H; Horiguchi H; Hashimoto H; Matsuda S; Fushimi K
    Pancreas; 2013 Mar; 42(2):260-4. PubMed ID: 23000890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
    Chen HM; Chen JC; Hwang TL; Jan YY; Chen MF
    Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
    Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
    Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
    Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gabexate mesilate (FOY), a new synthetic protease inhibitor, in the treatment of shock. An Italian multicenter study].
    Novelli GP; Innocenti P; Livi P
    Minerva Anestesiol; 1993 May; 59(5):247-53. PubMed ID: 8355865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.